Skip to main content
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.98
-0.04 (-0.33%)
May 14, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Animal Models Selling
301.45M
Log In
Log In
Log In
Log In
Animal Models Selling Growth
53.09%
Log In
Log In
Log In
Log In
Pre-clinical Pharmacology and Efficacy Evaluation
213.70M
Log In
Log In
Log In
Log In
Pre-clinical Pharmacology and Efficacy Evaluation Growth
4.37%
Log In
Log In
Log In
Log In
Antibody Development
194.34M
Log In
Log In
Log In
Log In
Antibody Development Growth
31.70%
Log In
Log In
Log In
Log In
Gene-editing
82.13M
Log In
Log In
Log In
Log In
Gene-editing Growth
15.64%
Log In
Log In
Log In
Log In
Other
570.18K
Log In
Log In
Log In
Log In
Other Growth
-6.07%
Log In
Log In
Log In
Log In
Other
570.18K
Log In
Log In
Log In
Log In
Other Growth
-6.07%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Other
118.38M
Log In
Log In
Log In
Log In
Other Growth
51.60%
Log In
Log In
Log In
Log In
China
341.01M
Log In
Log In
Log In
Log In
China Growth
1.92%
Log In
Log In
Log In
Log In
United States
332.79M
Log In
Log In
Log In
Log In
United States Growth
59.88%
Log In
Log In
Log In
Log In
Other
118.38M
Log In
Log In
Log In
Log In
Other Growth
51.60%
Log In
Log In
Log In
Log In
South Korea
-
Log In
Log In
Log In
Log In